Firms
Theme

UNM

Unum Group · NYSE

News

2 latest

Zacks Investment Research

Unum Group's Premium Growth and Share Buybacks Support 2026 Outlook

Unum Group projects 4-7% premium growth and adjusted operating EPS of $8.60-$8.90 in 2026, supported by strong persistency, higher sales, and digital investments. The company plans $1 billion in buybacks but faces headwinds from rising claims costs and declining investment income. Comparable industry players NMI Holdings, Palomar Holdings, and Arch Capital also show positive earnings momentum.

Zacks Investment Research

Can Unum Group's Colonial Life Sustain Its Earnings Momentum?

Unum Group's Colonial Life segment demonstrated solid performance in Q2 2026 with adjusted operating income rising 11.9% and premium income increasing 3.3% to $477.4M. The segment benefited from favorable claims experience, higher investment income (up 17.6%), and a strong 19.4% ROE. However, persistency showed a slight decline and modest premium growth suggests the need for sustained sales momentum. Peers Aflac and MetLife also showed strength in their group benefits segments.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $UNM · 0 threads

Sign in to post on $UNM

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev